Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- NAD+ Precursor Supplementation in Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of NAD+ Precursor Supplementation in Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04817111).
- NAFLDIndependent statistical analysis of Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Naltrexone for Impulse Control Disorders in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone for Impulse Control Disorders in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052831).
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NAMESIndependent statistical analysis of Northwestern University and Access Community Health Network Medication Education Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578577).
- Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: Complete Statistical AnalysisIndependent statistical analysis of Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: Complete Statistical AnalysisIndependent statistical analysis of Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NASH-CXIndependent statistical analysis of Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis: primary endpoint results,…
- NASQIndependent statistical analysis of Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: Complete Statistical AnalysisIndependent statistical analysis of National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- National Prevalence and Impact of Noninvasive Prenatal Testing: Complete Statistical AnalysisIndependent statistical analysis of National Prevalence and Impact of Noninvasive Prenatal Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02284399).
- Natriuretic Peptides – Predictors of In-hospital and Long-term Major Adverse Cardiac Events After Emergency Surgery?: Complete Statistical AnalysisIndependent statistical analysis of Natriuretic Peptides - Predictors of In-hospital and Long-term Major Adverse Cardiac Events After Emergency Surgery?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NATRONIndependent statistical analysis of A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I – II Trial: Complete Statistical AnalysisIndependent statistical analysis of Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NavigatorIndependent statistical analysis of A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3…
- Navigator II Continuous Glucose Monitor Home Use Study: Complete Statistical AnalysisIndependent statistical analysis of Navigator II Continuous Glucose Monitor Home Use Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01455064).
- NAVIOIndependent statistical analysis of A Retrospective Study of the Navio Robotic-assisted Surgical System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03072459).
- NB-001 in Children and Adolescents With 22q11 Deletion Syndrome: Complete Statistical AnalysisIndependent statistical analysis of NB-001 in Children and Adolescents With 22q11 Deletion Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05290493).
- NCT01009034Independent statistical analysis of Concentrations of Maraviroc in the Semen of HIV-Infected Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01009034).
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nebulized Hypertonic Saline for Inpatient Use in COPD: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Inpatient Use in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266875).
- Nebulized Hypertonic Saline for Mechanically Ventilated Children: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Mechanically Ventilated Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01945944).
- NefigardIndependent statistical analysis of Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Negative Beta Glucan in ICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Negative Beta Glucan in ICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01734525).
- Neo ALTTOIndependent statistical analysis of Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553358).
- Neo TrioIndependent statistical analysis of Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: Complete Statistical AnalysisIndependent statistical analysis of Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04512430).
- Neo-Synalar Modified 48 Hour Patch Test: Complete Statistical AnalysisIndependent statistical analysis of Neo-Synalar Modified 48 Hour Patch Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168478).
- Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03747120).
- Neoadjuvant Immunotherapy in Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Immunotherapy in Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04434560).
- Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04869137).
- Neoadjuvant Pazopanib in Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Pazopanib in Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01361113).
- Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2: primary endpoint results, effect estimate…
- Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00828308).
- NeohttpIndependent statistical analysis of Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02345772).
- NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: Complete Statistical AnalysisIndependent statistical analysis of NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03522675).
- NEOMUNIndependent statistical analysis of Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03197467).
- Neonatal Outcome by Reason for Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neonatal Outcome by Reason for Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01818518).
- NEOTHROCOVIDIndependent statistical analysis of Thromboembolic Risk Screening in Patients With Cancer and COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04616846).
- Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: Complete Statistical AnalysisIndependent statistical analysis of Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nesiritide Use Following Cardiac Surgery in Infants: Complete Statistical AnalysisIndependent statistical analysis of Nesiritide Use Following Cardiac Surgery in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00281671).
- NEST-1Independent statistical analysis of Combination Immunotherapy in Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05571293).
- NeuHFRecoverIndependent statistical analysis of NMES in HF Patients to Improve Functional Recovery Following Hospitalization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05338437).
- Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: Complete Statistical AnalysisIndependent statistical analysis of Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04017442).